nostic services in the community when necessary. Thus they could start investigations in the home, take specimens, and advise on treatment if required by the general practitioner, the objective being to avoid admission to hospital. The team would "hand hold" but not take over the practitioner's role and care. The relationship between the general practitioner and hospital team will need to be nurtured and be built on Despite the long known extrapyramidal side effects of even the weak dopamine receptor blocking agents'2 such drugs are frequently prescribed inappropriately.3 Acute dystonic reactions, drug induced parkinsonism, and akathisia usually resolve quickly when the offending drug is withdrawn. The tardive dyskinesias, however, including orofacial dyskinesia, may take years to resolve and some may be permanent. 4 There is no effective symptomatic treatment for these. Medicolegal action in which the original reason for the prescription is questioned is remarkably rare in Britain. We wish to emphasise the distress caused to patients by frequent abuse of this class of drug. The long term use ofphenothiazines, butyrophenones, and metoclopramide for dizziness, nausea, and night sedation is inappropriate and must be avoided to prevent extrapyramidal reactions. Compound preparations that contain a phenothiazine have little or no place in present day treatment
Case Reports
Case I -An elderly woman had seen her family doctor to complain of nonvertiginous dizziness. In retrospect it was clear that this was a problem of anxiety and agoraphobia. Prochlorperazine S mg three times a day had been prescribed and she had been on the medication for 18 months when she developed a tremor, her gait slowed, and she became clumsy with her hands. On examination a moderately severe parkinsonian syndrome was evident. The prochlorperazine was stopped and when seen four months later she had almost completely recovered. In the original letter ofreferral the fact that she was on prochlorperazine continuously had not been mentioned.
Case 2-A middle aged woman with a six month history of mild tremor with some clumsiness and slowing down was seen. On examination she had clear signs of a moderately severe parkinsonian syndrome. It emerged that for the preceding three years she had taken the compound preparation Stelabid (trifluoperazine and isopropamide). The drug had been prescribed by her general practitioner for vaguely described abdominal pain and nausea and she felt it had helped her. This medication was stopped and three months later her parkinsonian syndrome was improving without the need for antiparkinsonian medication. The original letter of referral did not mention that she was taking Stelabid.
Case 3-A middle aged man went to see his general practitioner complaining of anxiety and depressive feelings. The first medication prescribed for this was the compound preparation Motival (fluphenazine and nortriptyline) one tablet three times a day. Two months later he began to slow down generally but no tremor developed. He was referred with a diagnosis of parkinsonism but no mention of his medication. The clinical signs confirmed the diagnosis, the medication was stopped, and over the next few months he made a full recovery without the need for any specific treatment for the parkinsonism and without any alteration in his anxiety and depressive feelings.
Case 4-An elderly woman was seen with involuntary movements mainly of her pelvis. These were seen by several physicians and thought to be hysterical until it was discovered that she had been receiving metoclopramide for two years and tardive dyskinesia was diagnosed. Metoclopramide had originally been prescribed for a persistent feeling of nausea. The drug had apparently helped and she had taken it every day since. The drug was stopped, but it was a full year before there was any sign of the movements improving and after two years they had still not disappeared. The nausea did not recur when metoclopramide was stopped.
Case S-A man in late middle age developed an abrupt onset right hemiparesis from which he made a good recovery, but he became restless at night in the recovery phase and-was put on chlorpromazine 100 mg at night. This was prescribed repeatedly and when seen two years later he had bilateral dystonic movements but predominantly on the side of the hemiparesis; he also had facial contortions on both sides. It was thought that this was predominantly a tardive dystonia with unusually asymmetric manifestations secondary to the preceding stroke. Chlorpromazine was stopped but until now there has been no recovery. The fact that he was taking chlorpromazine was not noted in the letter of referral and the patient believed he was taking a "sleeping tablet." Case 6-A middle aged man had suffered with moderate anxiety related problems throughout his life and then became depressed. He had been taking benzodiazepine for years and this was withdrawn and replaced with Triptafen (a compound preparation of amitriptyline and perphenazine) one tablet four times a day. Within two weeks he developed facial involuntary movements that upset him a great deal. After a further three months, at his insistence, the Triptafen was discontinued but was replaced with chlorpromazine. On examination he had a noticeable blepharospasm, a lot of grimacing, and masticatory movements of his palate. The variant of tardive dyskinesia known as Meige's syndrome was diagnosed. Chlorpromazine was stopped and over the next three months the involuntary movement diminished.
Discussion
The cases described here represent a selection of patients with iatrogenic movement disorders other than acute dystonic reactions who were encountered in a single neurological practice over one year. Adverse reactions, such as involuntary movements, to appropriate drug treatment for psychoses were excluded.
The inappropriate prescription of prolonged courses of prochlorperazine for dizziness, metoclopramide for chronic nausea, or chlorpromazine as a hypnotic agent contributes to many of these adverse reactions. Prochlorperazine is appropriate treatment for acute vertigo but its prolonged use or use for non-specific dizziness is undesirable. For true recurrent vertigo alternatives are available such as betahistine, which does not carry the same risk of causing movement disorders. Similarly metoclopramide, which is useful in the short term for treating acute nausea, should not be used in managing undiagnosed chronic nausea, which, like chronic undiagnosed dizziness, is often a psychosomatic symptom. In addition phenothiazines should not be used for night sedation. For the short term management of insomnia clear alternatives are widely available.
Our patients also exemplify the problems that can be encountered with the use of combined preparations containing phenothiazines. Such compound preparations include Motival, Triptafen,. Motipress, and Parstelin, marketed as antidepressants, and the gastrointestinal tract sedative Stelabid. The use of these combined preparations cannot be justified for the treatment of depression or anxiety and certainly not as first line treatment when a tricyclic antidepressant or monoamine oxidase inhibitor should be used alone. Even in the rare circumstances when an antidepressant and a phenothiazine need to be combined a .fixed ratio of the two constituents is against recommended treatment practices. 5 We have highlighted some of the pitfalls with the prescribing of dopamine receptor blocking agents. There are numerous other pitfalls, such as prescribing Serenace (haloperidol) instead of Serenid (oxazepam) or failing to realise that flupenthixol (marketed as an antidepressant) is a powerful dopamine receptor blocking agent. Improved prescribing habits will reduce the incidence of these side effects. Nevertheless, some drug induced extrapyramidal reactions will continue to occur and a high index of suspicion is required to diagnose these. This requires the important step of recognising that the patient is receiving a dopamine receptor blocking agent. The lack ofmention ofthe offending drug in most of the letters of referral leads us to believe that these side effects are underestimated by general practitioners. Realising that these side effects occur may prevent wrong diagnosis, such as hysterical movement disorder, and, by allowing early withdrawal of the drug, may hasten improvement.6
Is there a link between eating chocolate and the incidence of"facial spots," and if so why?
The overall clinical impression that used to prevail among dermatologists until 10-15 years ago was that there was some relation between acne and diet. 
